PCSK9 inhibition in statin-intolerant HeFH patients: What's new?

Eur J Prev Cardiol. 2017 Sep;24(14):1525-1527. doi: 10.1177/2047487317721980. Epub 2017 Jul 21.

Manuela Casula¹, Angela Pirillo^{2

3}, Giuseppe Danilo Norata^{4

5}, Alberico Luigi Catapano^{1

3}

¹ 1 Epidemiology and Preventive Pharmacology Centre (SEFAP), Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
² 2 Center for the Study of Atherosclerosis, E Bassini Hospital, Cinisello Balsamo, Milan, Italy.
³ 3 IRCCS MultiMedica, Sesto S. Giovanni, Milan, Italy.
⁴ 4 Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
⁵ 5 School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia.

No abstract available

Publication types